Pieris Pharmaceuticals
Stock Forecast, Prediction & Price Target

Pieris Pharmaceuticals Financial Estimates

Pieris Pharmaceuticals Revenue Estimates

Pieris Pharmaceuticals EBITDA Estimates

Pieris Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$31.41M
 
N/A
$25.90M
 
-17.55%
$42.81M
 
65.27%
Avg: $7M
Low: $7M
High: $7M
avg. -83.64%
Avg: $48.93M
Low: $48.93M
High: $48.93M
avg. 599.03%
Net Income
 
% change YoY
$-43.36M
 
N/A
$-31.25M
 
27.93%
$-24.54M
 
21.46%
Avg: $-26.29M
Low: $-326.48K
High: $-326.48K
avg. -7.15%
Avg: $-27.91M
Low: $-27.91M
High: $-27.91M
avg. -6.16%
EBITDA
 
% change YoY
$-48.14M
 
N/A
$-35.30M
 
26.67%
$-22.76M
 
35.52%
Avg: $-5.44M
Low: $-5.44M
High: $-5.44M
avg. 76.05%
Avg: $-38.09M
Low: $-38.09M
High: $-38.09M
avg. -599.03%
EPS
 
% change YoY
-$53.75
 
N/A
-$33.71
 
37.28%
-$21.8
 
35.33%
Avg: -$0.29
Low: -$0.29
High: -$0.29
avg. 98.66%
Avg: -$24.8
Low: -$24.8
High: -$24.8
avg. -8451.72%
Operating Expenses
 
% change YoY
$79.56M
 
N/A
$61.20M
 
-23.07%
$72.56M
 
18.56%
Avg: $3.53M
Low: $3.53M
High: $3.53M
avg. -95.13%
Avg: $24.69M
Low: $24.69M
High: $24.69M
avg. 599.03%

FAQ

What is Pieris Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -6.65% in 2025-2026.

We have gathered data from 1 analysts. Their low estimate is -326.48K, average is -26.29M and high is -326.48K.

What is Pieris Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 257.69% in 2025-2026.

We have gathered data from 1 analysts. Their low revenue estimate is $7M, average is $7M and high is $7M.

What is Pieris Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -4176.52% in 2025-2026.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.29, average is -$0.29 and high is $-0.29.